Group One Trading’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-103,500
| Closed | -$6.08M | – | 8282 |
|
|
2023
Q4 | $6.08M | Buy |
103,500
+28,100
| +37% | +$1.58M | 0.02% | 991 |
|
|
2023
Q3 | $3.28M | Sell |
75,400
-25,500
| -25% | -$910K | 0.01% | 1237 |
|
|
2023
Q2 | $3.65M | Buy |
100,900
+60,400
| +149% | +$2.49M | 0.01% | 1209 |
|
|
2023
Q1 | $1.51M | Sell |
40,500
-5,400
| -12% | -$243K | 0.01% | 1779 |
|
|
2022
Q4 | $2.08M | Buy |
45,900
+37,800
| +467% | +$2.45M | ﹤0.01% | 1782 |
|
|
2022
Q3 | $566K | Sell |
8,100
-60,100
| -88% | -$4.45M | ﹤0.01% | 3118 |
|
|
2022
Q2 | $4.58M | Buy |
68,200
+11,200
| +20% | +$712K | 0.01% | 1364 |
|
|
2022
Q1 | $4.69M | Buy |
57,000
+23,500
| +70% | +$2.4M | ﹤0.01% | 1601 |
|
|
2021
Q4 | $4.91M | Sell |
33,500
-42,800
| -56% | -$6.64M | ﹤0.01% | 1713 |
|
|
2021
Q3 | $13.5M | Buy |
76,300
+58,700
| +334% | +$9.44M | 0.01% | 849 |
|
|
2021
Q2 | $2.84M | Sell |
17,600
-43,200
| -71% | -$6.94M | ﹤0.01% | 2267 |
|
|
2021
Q1 | $10.4M | Sell |
60,800
-43,500
| -42% | -$8.61M | 0.02% | 912 |
|
|
2020
Q4 | $22.9M | Buy |
104,300
+40,000
| +62% | +$8.65M | 0.04% | 390 |
|
|
2020
Q3 | $10.7M | Sell |
64,300
-24,100
| -27% | -$3.3M | 0.03% | 493 |
|
|
2020
Q2 | $10.1M | Sell |
88,400
-67,400
| -43% | -$6.54M | 0.05% | 437 |
|
|
2020
Q1 | $12M | Buy |
155,800
+39,700
| +34% | +$3.56M | 0.1% | 200 |
|
|
2019
Q4 | $15M | Sell |
116,100
-50,500
| -30% | -$4.87M | 0.1% | 221 |
|
|
2019
Q3 | $13M | Buy |
166,600
+97,800
| +142% | +$9.18M | 0.1% | 201 |
|
|
2019
Q2 | $7.09M | Buy |
68,800
+66,300
| +2,652% | +$5.16M | 0.06% | 361 |
|
|
2019
Q1 | $183K | Buy |
2,500
+1,500
| +150% | +$102K | ﹤0.01% | 2773 |
|
|
2018
Q4 | $42K | Sell |
1,000
-5,200
| -84% | -$207K | ﹤0.01% | 3650 |
|
|
2018
Q3 | $292K | Sell |
6,200
-4,300
| -41% | -$239K | ﹤0.01% | 2729 |
|
|
2018
Q2 | $518K | Buy |
10,500
+6,200
| +144% | +$234K | ﹤0.01% | 2255 |
|
|
2018
Q1 | $132K | Sell |
4,300
-31,200
| -88% | -$866K | ﹤0.01% | 3080 |
|
|
2017
Q4 | $648K | Buy |
35,500
+35,300
| +17,650% | +$548K | ﹤0.01% | 2049 |
|
|
2017
Q3 | $2K | Sell |
200
-800
| -80% | -$4.63K | ﹤0.01% | 4661 |
|
|
2017
Q2 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 4482 |
|
|
2017
Q1 | $5K | Buy |
+1,000
| New | +$5.48K | ﹤0.01% | 4296 |
|
|
2015
Q4 | – | Sell |
-1,000
| Closed | -$34K | – | 5191 |
|
|
2015
Q3 | $34K | Sell |
1,000
-10,500
| -91% | -$317K | ﹤0.01% | 3762 |
|
|
2015
Q2 | $362K | Buy |
+11,500
| New | +$339K | 0.01% | 2063 |
|
Other funds holding MRTX
Group One Trading's MRTX Position: Q1 2024 in Review
Group One Trading sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 414,114 shares — an estimated $24.3M sold.
Group One Trading first reported a position in MRTX in Q2 2015 and held it in 17 quarters. The position peaked at $24.3M in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.
- Group One Trading reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Group One Trading sold 414,114 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $24.3M.
- Group One Trading first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2015 and held it in 17 quarters.
- Group One Trading's Mirati Therapeutics, Inc. Common Stock position peaked at $24.3M in Q4 2023.
- 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.